UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adjuvant Gemcitabine Alone Versus Gemcitabine-Based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: A Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study

Journal of clinical oncology, 2010-10, Vol.28 (29), p.4450-4456

2010

Volltextzugriff (PDF)

Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation

Cochrane database of systematic reviews, 2007-10 (4), p.CD005353

2007

Volltextzugriff (PDF)

Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study

The lancet oncology, 2016-02, Vol.17 (2), p.153-163

2016

Volltextzugriff (PDF)

Non-analgesic effects of opioids: opioid-induced nausea and vomiting: mechanisms and strategies for their limitation

Current pharmaceutical design, 2012-12, Vol.18 (37), p.6043-6052

2012

Volltextzugriff (PDF)

Once-Weekly Semaglutide in Adults with Overweight or Obesity

The New England journal of medicine, 2021-03, Vol.384 (11), p.989-1002

2021

Volltextzugriff (PDF)

Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study

The lancet oncology, 2016-02, Vol.17 (2), p.200-211

2016

Volltextzugriff (PDF)

Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials

Journal of clinical oncology, 2015-03, Vol.33 (8), p.910-915

2015

Volltextzugriff (PDF)

Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial

The lancet oncology, 2017-05, Vol.18 (5), p.599-610

2017

Volltextzugriff (PDF)

Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database

JNCI : Journal of the National Cancer Institute, 2021-04, Vol.113 (4), p.400-407

2021

Volltextzugriff (PDF)

Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer

Journal of clinical oncology, 2018-01, Vol.36 (1), p.7-13

2018

Volltextzugriff (PDF)

Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial

The lancet oncology, 2017-05, Vol.18 (5), p.623-630

2017

Volltextzugriff (PDF)

Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting

The New England journal of medicine, 2016-04, Vol.374 (14), p.1356-1367

2016

Volltextzugriff (PDF)

Adverse events in people taking macrolide antibiotics versus placebo for any indication

Cochrane database of systematic reviews, 2019-01, Vol.1 (1), p.CD011825

2019

Volltextzugriff (PDF)

Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial

Annals of oncology, 2020-11, Vol.31 (11), p.1553-1560

2020

Volltextzugriff (PDF)

Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis

Nature communications, 2021-10, Vol.12 (1), p.5954-7, Article 5954

2021

Volltextzugriff (PDF)

Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation

Journal of clinical oncology, 2020-05, Vol.38 (13), p.1378-1388

2020

Volltextzugriff (PDF)

Obinutuzumab for the First-Line Treatment of Follicular Lymphoma

The New England journal of medicine, 2017-10, Vol.377 (14), p.1331-1344

2017

Volltextzugriff (PDF)

Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials

JAMA : the journal of the American Medical Association, 2020-02, Vol.323 (5), p.432

2020

Volltextzugriff (PDF)

Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet (British edition), 2019-11, Vol.394 (10213), p.2012-2024

2019

Volltextzugriff (PDF)

Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial

Journal of clinical oncology, 2017-08, Vol.35 (22), p.2490-2498

2017

Volltextzugriff (PDF)

The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting

Annals of oncology, 2017-06, Vol.28 (6), p.1260-1267

2017

Volltextzugriff (PDF)

Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference

Annals of oncology, 2010-05, Vol.21 (suppl-5), p.v232-v243

2010

Volltextzugriff (PDF)

Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study

Blood, 2014-05, Vol.123 (19), p.2944-2952

2014

Volltextzugriff (PDF)

1 – 25 von 9.954

Suche als RSS-Feed

Aktive Filter

SpracheNorwegisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(8.532)
Mit Volltextzugriff
(6.378)

Publikationsform

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(9.731)
Nausea - Chemically Induced
(8.469)
Science & Technology
(7.199)
Life Sciences & Biomedicine
(7.154)
Female
(6.575)
Male
(5.457)
Vomiting - Chemically Induced
(5.138)
Adult
(5.046)
Middle Aged
(4.996)
Aged
(3.744)
Oncology
(2.641)
Biological And Medical Sciences
(2.578)
Medical Sciences
(2.517)
Antineoplastic Agents - Adverse Effects
(2.200)
Nausea
(1.989)
Pharmacology. Drug Treatments
(1.857)
Chemotherapy
(1.641)
Antiemetics - Therapeutic Use
(1.622)
Treatment Outcome
(1.593)
Nausea - Prevention & Control
(1.587)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(9.948)
Journals@Ovid Full Text
(4.435)
IngentaConnect
(4.077)
EZB Electronic Journals Library
(3.240)
Single Journals
(2.469)
IngentaConnect Journals
(2.109)
Wiley-Blackwell Journals
(1.414)
Springer Journals
(1.364)
Access via ScienceDirect (Elsevier)
(1.319)
Wiley Online Library
(1.034)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(957)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(911)
Access via Taylor & Francis
(403)
Taylor & Francis
(352)
Access via Taylor & Francis
(346)
Access via SAGE
(313)
BMJ Journals
(269)
Oxford journals
(265)
Oxford Journals 2020 Medicine
(216)
Springer Book Series
(208)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Supportive Care In Cancer
(348)
Gan To Kagaku Ryoho
(311)
Journal Of Clinical Oncology
(217)
Cancer
(187)
Cancer Chemotherapy And Pharmacology
(140)
Cancer Treatment Reports
(139)
Anesthesia And Analgesia
(129)
Bmj
(111)
American Journal Of Clinical Oncology
(110)
European Journal Of Cancer
(108)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Adjuvant Gemcitabine Alone Versus Gemcitabine-Based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: A Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study

Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation

Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study

Non-analgesic effects of opioids: opioid-induced nausea and vomiting: mechanisms and strategies for their limitation

Once-Weekly Semaglutide in Adults with Overweight or Obesity

Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results

Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study

Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials

Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial

Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database

Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer

Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial

Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting

Adverse events in people taking macrolide antibiotics versus placebo for any indication

Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial

Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis

Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation

Obinutuzumab for the First-Line Treatment of Follicular Lymphoma

Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials

Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial

The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting

Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference

Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial

Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study

Aktive Filter

Suchergebnisse filtern